Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biopharma 'Keeps Executing and Securing Milestones'

The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...
Streetwise Reports | December 19, 2019 |

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

Biopharma's New License Agreement with Gilead 'Brings Strong Validation and Economics'

The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report. In a July 22 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) entered an agreement concerning its SABER technology and SAB...
Streetwise Reports | July 24, 2019 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

Why this company is making new discoveries in re-emerging camps in Ontario

The province of Ontario has a rich history of gold mining, while the yellow metal is Canada’s most valuable mined metal, totaling C$10.3 billion in production as recently as 2019. In total, Canadian mines produced roughly 175 tonnes of gold in 2019, up fro...
Stockhouse Editorial | June 4, 2021 |

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |

Health Canada Approvals Set Stage for Revenue Generation

(Click image to play video) From the Earth to the Bottle! That’s one Calgary pharmaceutical company’s motto. Voyageur Pharmaceuticals Ltd. ( TSX-V.VM , OTC: VYYRF , Forum ) is focused on sourcing and manufacturing iod...
Dave Jackson | February 25, 2021 |

An Unparalleled Opportunity in the Rising Mega-trend of Rechargeable Batteries

The rechargeable battery market has been generating plenty of attention over the last several years thanks to the growing demand from the automotive industry and — in particular — electric vehicles. In line with this, the demand for rechargeable batteries will continue ...
Jocelyn Aspa | April 27, 2021 |

Positioned for Long-Term Growth: The Cannabis Co. that’s Driving Strong Revenue Results

(CLICK IMAGE TO PLAY VIDEO) Love in the air in the cannabis space again…especially for the last year, year-and-a-half. But there’s a cannabis company that’s not only feeling the love but delivering it to shareholders and investors...
Dave Jackson | June 28, 2021 |

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

When the Corona Pandemic started in November 2019 in Wuhan, China, nobody could have guessed the extent of the disease. Socially, economically and politically, Covid-19 has turned the world upside down. With increasing knowledge in dealing with the Corona Virus, people around ...
Mario Hose | September 23, 2020 |
1 2 3 4 5 6 7 8 9 10 ...